Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Entropy (Basel, Switzerland)
|
December 3, 2020
End-to-End Deep Neural Networks and Transfer Learning for Automatic Analysis of Nation-State Malware
Ishai Rosenberg, Guillaume Sicard, Eli Omid David
Annales Pharmaceutiques Francaises
|
April 19, 2023
[Advanced therapy medicinal products' (ATMP) pharmaceutical circuit in France: Current situation and outlook]
Benjamin Fabri, Guillaume Sicard, Laurence Gauthier-Villano, et al.
Pharmaceutics
|
August 16, 2020
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
March 21, 2024
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Guillaume Sicard, Dorian Protzenko, Sarah Giacometti, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 26, 2018
Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles
Anne Rodallec, Guillaume Sicard, Raphaelle Fanciullino, et al.
Pharmaceutics
|
December 2, 2020
Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
Guillaume Sicard, Clément Paris, Sarah Giacometti, et al.
International Journal of Pharmaceutics
|
April 8, 2024
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models
Mathilde Dacos, Benoît Immordino, Erwan Diroff, et al.
British Journal of Haematology
|
September 11, 2023
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients
Melanie Donnette, Mourad Hamimed, Joseph Ciccolini, et al.
International Journal of Nanomedicine
|
November 15, 2018
From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, et al.
Anti-Cancer Drugs
|
January 3, 2020
Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Entropy (Basel, Switzerland)
|
December 3, 2020
End-to-End Deep Neural Networks and Transfer Learning for Automatic Analysis of Nation-State Malware
Ishai Rosenberg, Guillaume Sicard, Eli Omid David
Annales Pharmaceutiques Francaises
|
April 19, 2023
[Advanced therapy medicinal products' (ATMP) pharmaceutical circuit in France: Current situation and outlook]
Benjamin Fabri, Guillaume Sicard, Laurence Gauthier-Villano, et al.
Pharmaceutics
|
August 16, 2020
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
March 21, 2024
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Guillaume Sicard, Dorian Protzenko, Sarah Giacometti, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 26, 2018
Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles
Anne Rodallec, Guillaume Sicard, Raphaelle Fanciullino, et al.
Pharmaceutics
|
December 2, 2020
Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
Guillaume Sicard, Clément Paris, Sarah Giacometti, et al.
International Journal of Pharmaceutics
|
April 8, 2024
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models
Mathilde Dacos, Benoît Immordino, Erwan Diroff, et al.
British Journal of Haematology
|
September 11, 2023
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients
Melanie Donnette, Mourad Hamimed, Joseph Ciccolini, et al.
International Journal of Nanomedicine
|
November 15, 2018
From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, et al.
Anti-Cancer Drugs
|
January 3, 2020
Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, et al.
Page
of 2